The company is an internationally leading life science research and development service enterprise. It operates in China, the US, and the UK, and has more than 11,000 employees, providing R&D solutions to and maintaining good partnerships with partners in North America, Europe, Japan and China. The company is a leading full-process integrated pharmaceutical research and development service platform with global operations. It is committed to helping customers accelerate drug innovation and providing full-process integrated drug research, development and production services from drug discovery to drug development. According to its main business type, the company can be divided into four service modules: laboratory services, CMC (small molecule CDMO) services, clinical research services, and macromolecular and cell and gene therapy services.
No Data